October 4, 2021
Life Sciences
  • Johnson & Johnson plans to ask the FDA early this week to authorize a booster shot of its COVID-19 vaccine. Recent federal data shows that the 15 million Americans who got Johnson & Johnson’s one-dose vaccine may have less protection than those who received shots made by Moderna Inc. or Pfizer Inc.-BioNTech SE. The FDA said its advisory committee will meet on October 14 and 15 to discuss the use of booster doses of Johnson & Johnson’s and Moderna’s COVID-19 vaccines. On October 26, the committee will discuss an anticipated request from Pfizer to amend its emergency use authorization for the use of its COVID-19 vaccine in children ages 5-11. (Article here)